
Scientists at Rockefeller University say a common amino acid called arginine can help the body’s immune cells spot cancer and viruses hiding inside cells.
Quick Take
- Rockefeller University researchers found that low arginine levels weaken a key immune warning system in the body.
- The study, published in the journal Cell, identified 414 proteins that drop when arginine is scarce.
- Mice given more arginine developed fewer colon tumors and recovered better from flu and COVID-19.
- The findings come from cell and mouse experiments only, not human clinical trials.
How Arginine Powers the Immune Alarm System
Arginine is a building block of protein found in foods like meat, nuts, and dairy. Rockefeller University researchers discovered that when arginine runs low, cells struggle to produce enough MHC class I, a molecule that displays warning signs on a cell’s surface. Those signs tell immune cells when something has gone wrong inside, whether from a virus or a tumor.
Without enough MHC class I on the surface, immune cells called T cells cannot see the danger signals. The study, titled “Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection,” ties this breakdown directly to arginine shortages inside cells.
A Stalled Protein Factory
Researchers found a specific reason why this happens. Cells build proteins using tiny machines called ribosomes, which read genetic instructions and link amino acids together in order. When arginine is scarce, ribosomes stall right at the points in the genetic code that call for arginine while building MHC class I proteins, slowing down production of the immune warning signal.
The research team also found 414 proteins that dropped to unusually low levels under arginine-limited conditions. Among them were HLA-A, HLA-B, and HLA-C, the genes responsible for building MHC class I molecules. That overlap gave scientists a direct molecular link between arginine shortage and a weaker immune alarm system.
Results Showed Up in Mice With Cancer and Viruses
The lab tested the idea in living animals, not just cells in a dish. Mice fed low-arginine diets developed more colon tumors, while mice given extra arginine developed fewer tumors, according to coverage of the Rockefeller-led study.
The effect also extended to viral infections. Mice with higher arginine intake lost less weight and survived influenza more often than mice with lower arginine levels. In mice infected with SARS-CoV-2, the virus that causes COVID-19, higher arginine levels were linked to lower detectable virus in the lungs and less tissue damage and inflammation.
Why This Isn’t a Supplement Recommendation Yet
The experiments described so far involve lab-grown cells and mice, not people. No human clinical trial has tested whether taking arginine supplements prevents or treats cancer, flu, or COVID-19 in humans. That gap matters because how a nutrient behaves in a mouse does not always match how it behaves in a person’s body, especially with cancer, where tumors can consume nutrients differently than healthy tissue.
A simple supplement (arginine) could help your immune system fight cancer and viral infections | Rockefeller University, ScienceDaily
A common amino acid found in everyday foods could play a surprisingly important role in helping the immune system recognize cancer and fight… pic.twitter.com/w0H9qsfMfp
— Owen Gregorian (@OwenGregorian) November 16, 2026
Some early coverage of the study has already framed arginine as a potential health supplement, which risks getting ahead of the science. The actual evidence supports a specific biological mechanism and consistent results in animal models. It does not yet prove that buying arginine pills off a store shelf would protect a person from cancer or a respiratory virus.
What Comes Next for This Research
Scientists studying arginine’s role in cancer biology note that the amino acid affects several different pathways in the body, some of which can work for or against tumor control depending on the tissue involved. That complexity means follow-up studies in humans, with controlled dosing and measured outcomes, would be needed before doctors could recommend arginine as a treatment or preventive step for cancer or viral illness.
For now, the discovery stands as a clear example of basic science uncovering a real biological mechanism, arginine’s role in powering the immune system’s warning signals, while leaving the larger question of real-world human benefit for future research to answer.
Sources:
youtube.com, medicaldialogues.in, news.ssbcrack.com, newsweek.com, pmc.ncbi.nlm.nih.gov, ua.news, nutritioninsight.com













